{"id":"tab014-monoclonal-antibody-injection","safety":{"commonSideEffects":[{"rate":null,"effect":"Unspecified adverse event"}]},"_chembl":{"chemblId":"CHEMBL2109418","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"TAB014 is a monoclonal antibody designed to bind to a specific protein or receptor, thereby modulating its activity and exerting its therapeutic effects.","oneSentence":"TAB014 is a monoclonal antibody that targets an unspecified molecular target to treat various conditions.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:37:12.358Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Unspecified indication"}]},"trialDetails":[{"nctId":"NCT05461339","phase":"PHASE3","title":"TAB014 Compared to Lucentis® in Patients with Neovascular Age-related Macular Degeneration","status":"ACTIVE_NOT_RECRUITING","sponsor":"BioDlink Biopharm Co., Ltd.","startDate":"2022-06-28","conditions":"Neovascular Age-related Macular Degeneration","enrollment":488},{"nctId":"NCT03675880","phase":"PHASE1","title":"TAB014(Drug Code) in Wet( Neovascular)Age-related Macular Degeneration(AMD) Subjects","status":"UNKNOWN","sponsor":"Lee's Pharmaceutical Limited","startDate":"2018-06-15","conditions":"AMD","enrollment":24}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":46,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["TAB014"],"phase":"phase_3","status":"active","brandName":"TAB014 Monoclonal Antibody Injection","genericName":"TAB014 Monoclonal Antibody Injection","companyName":"BioDlink Biopharm Co., Ltd.","companyId":"biodlink-biopharm-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"TAB014 is a monoclonal antibody that targets an unspecified molecular target to treat various conditions. Used for Unspecified indication.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}